Labcorp Holdings Inc(LH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 26 at 4:09 PM ET (Korea 10/27 05:09)
Full metrics table
| Index | S&P 500 | P/E | 27.28 | EPS (ttm) | 12.09 | Insider Own | 0.4% | Shs Outstand | 80.9M | Perf Week | 3.47% |
| Market Cap | 26.75B | Forward P/E | 16.64 | EPS next Y | 8.05% | Insider Trans | -4.98% | Shs Float | 80.8M | Perf Month | 6.54% |
| Enterprise Value | 33.40B | PEG | 1.75 | EPS next Q | 4.64 | Inst Own | 100.73% | Short Float | 3.32% | Perf Quarter | 4.99% |
| Income | 1.00B | P/S | 1.86 | EPS this Y | 11.63% | Inst Trans | -0.67% | Short Ratio | 3.73 | Perf Half Y | 25.23% |
| Sales | 14.35B | P/B | 3.1 | EPS next 5Y | 9.53% | ROA | 5.48% | Short Interest | 2.68M | Perf YTD | 31.5% |
| Book/sh | 106.39 | P/C | 188.68 | EPS past 3/5Y | -9.18% -8.01% | ROE | 11.74% | 52W High | -3.48% ($341.80) | Perf Year | 18.04% |
| Cash/sh | 1.75 | P/FCF | 23.16 | Sales past 3/5Y | 5.55% -0.04% | ROIC | 6.6% | 52W Low | 34.92% ($244.52) | Perf 3Y | 60.21% |
| Dividend Est. | $2.95 (0.89%) | EV/EBITDA | 14.36 | EPS Y/Y TTM | 33.31% | Gross Margin | 26.82% | Volatility(W/M) | 2.57% 2.09% | Perf 5Y | 35.43% |
| Dividend TTM | 2.88 | EV/Sales | 2.33 | Sales Y/Y TTM | 6.41% | Oper. Margin | 11.35% | ATR (14) | 7.29 | Perf 10Y | 203.67% |
| Dividend Ex-Date | 2026/11/24 | Quick Ratio | 1.53 | EPS Q/Q | 28.47% | Profit Margin | 6.99% | RSI (14) | 63.58 | Recom | 1.71 |
| Dividend Gr. 3/5Y | 10.06% - | Current Ratio | 1.8 | Sales Q/Q | 5.78% | SMA20 | 4.19% ($316.63) | Beta | 0.88 | Target Price | $348.6 |
| Payout | 27.54% | Debt/Eq | 0.79 | Earnings | 2026/10/28 | SMA50 | 2.78% ($320.98) | Rel Volume | 0.91 | Prev Close | $328.95 |
| Employees | 71000 | LT Debt/Eq | 0.76 | EPS/Sales Surpr. | 4.41% 0.59% | SMA200 | 15.54% ($285.53) | Avg Volume(3M) | 0.72M | Price | $329.9 |
| IPO | 1988/7/7 | Option/Short | Yes/Yes | Trades | 14223 | Volume | 654,001 | Change | 0.29% |
🔬 Labcorp Holdings (LH) is a global leading healthcare diagnostics company that provides comprehensive life sciences solutions worldwide, spanning from routine health diagnostics for individual patients to complex clinical trial support for pharmaceutical companies and next-generation drug development.
Over the past 1 year, on the higher side
3% below its 1-year high.
Traded about as much as usual. That is 91% of its average volume.
Next earnings report: October 28
2 days to go. The ex-dividend date is November 24.
LH earns at a steady pace
Of every $100 in sales, $11.35 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +11.6% this year.
Tap to view numbers
Within its industry, it looks cheap
For a company earning $100 a year, you would pay $2,728. Peers typically go for $3,633. It is about in line with its own 5-year average.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +35.4%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.89% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 100.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #11 of 44 in the industry
Based on market cap of $27B.
MTD#9 Mettler-Toledo International Inc $33B PER 37.6 
DGX#10 Quest Diagnostics Inc $27B PER 24.2 LH#11 Labcorp Holdings Inc $27B PER 27.3 
GH#12 Guardant Health Inc $23B PER - 
MEDP#13 Medpace Holdings Inc $19B PER 37.5 
FAQ
What kind of company is LH?
LH belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of LH?
The market cap of LH is approximately $26.8B, ranking 497 within its sector.
Does LH pay dividends?
LH has a dividend yield of approximately 0.89%, with an annual dividend of $2.95.
What is the P/E ratio of LH?
LH has a P/E ratio of approximately 27.3x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for LH?
LH has recorded a 52-week high of $341.80 and a low of $244.52.
